CDK9-IN-8 is a highly effective and selective CDK9 inhibitor with an IC50 of 12 nM.
[1]. Li Y, et al. Discovery of a highly potent, selective and novel CDK9 inhibitor as an anticancer drug candidate. Bioorg Med Chem Lett. 2017 Aug 1;27(15):3231-3237.
















